Experimental and translational models of Alzheimer's disease: From neurodegeneration to novel therapeutic insights. [PDF]
J Prev Alzheimers DisKhan N, De S, Boddu S, Pravala N.
europepmc +1 more source
The relationship between amyloid-β peptide spectrum and the spastic paraparesis phenotype in autosomal dominant Alzheimer's disease. [PDF]
Alzheimers Res TherZoltowska KM +6 more
europepmc +1 more source
Systematic post-translational modification genome wide identifies therapeutic targets for Alzheimer's disease: evidence from multi-cohort analysis. [PDF]
J Prev Alzheimers DisWang X +5 more
europepmc +1 more source
Investigating the binding potential of the Melissa officinalis oil against Alzheimer's targets by molecular docking and in vitro evaluations. [PDF]
Sci RepKolouei A, Barati M, Abbas-Mohammadi M.
europepmc +1 more source
Bridging the gaps in alzheimer's disease: a comprehensive review of current and emerging therapies. [PDF]
InflammopharmacologyMostafa RE, Asaad GF.
europepmc +1 more source
The manipulator behind "Scissors": γ -secretase and its modulators in Alzheimer's disease. [PDF]
Front Aging NeurosciNing G +7 more
europepmc +1 more source
APP-C31 pathology as a target in neurodegenerative diseases. [PDF]
J Biomed SciYip KC, Ho WF, Liu Y, Dawe GS.
europepmc +1 more source
Amyloid Beta Oligomers as Early Triggers of Neuronal Cytoskeleton Dysfunction in Alzheimer's Disease. [PDF]
PathophysiologyGasca-Martínez Y +3 more
europepmc +1 more source
Changes in alpha- and beta-secretase in Alzheimer's disease
, 2016 Tyler, S +3 more
openaire +1 more source